{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:09:11Z","timestamp":1790352551240,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000521","name":"Canadian Cancer Society","doi-asserted-by":"publisher","award":["701596"],"award-info":[{"award-number":["701596"]}],"id":[{"id":"10.13039\/501100000521","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.radonc.2024.110605","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T19:39:59Z","timestamp":1730317199000},"page":"110605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Toxicity in patients receiving radiotherapy for ultracentral stage I non-small cell lung cancer: A secondary analysis of the LUSTRE randomized trial"],"prefix":"10.1016","volume":"202","author":[{"given":"Che Hsuan David","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Wierzbicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Parpia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijayananda","family":"Kundapur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Bujold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Filion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naseer","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Okawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Hirmiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V","family":"Louie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Swaminath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110605_b0005","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.radonc.2008.07.019","article-title":"Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD\/CVD in a non-randomized prospective phase II study","volume":"88","author":"Baumann","year":"2008","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.radonc.2024.110605_b0010","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ijrobp.2008.11.042","article-title":"Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study","volume":"75","author":"Fakiris","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110605_b0015","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.ijrobp.2005.05.034","article-title":"Clinical outcomes of a phase I\/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame","volume":"63","author":"Nagata","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110605_b0020","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.lungcan.2009.05.007","article-title":"Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial","volume":"68","author":"Ricardi","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2024.110605_b0025","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer","volume":"24","author":"Timmerman","year":"2006","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110605_b0030","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG oncology\/RTOG 0813 trial","volume":"37","author":"Bezjak","year":"2019","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110605_b0035","first-page":"1200","article-title":"The HILUS-trial-a prospective nordic multicenter phase 2 study of ultracentral lung tumors treated with stereotactic body radiotherapy","volume":"16","author":"Lindberg","year":"2021","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"10.1016\/j.radonc.2024.110605_b0040","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ijrobp.2017.11.022","article-title":"Normal tissue complication probability modeling of pulmonary toxicity after stereotactic and hypofractionated radiation therapy for central lung tumors","volume":"100","author":"Tekatli","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110605_b0045","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.clon.2021.05.005","article-title":"Late toxicity and long-term local control in patients with ultra-central lung tumours treated by intensity-modulated radiotherapy-based stereotactic ablative body radiotherapy with homogenous dose prescription","volume":"33","author":"Mihai","year":"2021","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110605_b0050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.lungcan.2008.12.016","article-title":"Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus","volume":"66","author":"Song","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2024.110605_b0055","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.ijrobp.2010.04.056","article-title":"Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non\u2013small-cell lung cancer: results of a phase II trial","volume":"80","author":"Bral","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110605_b0060","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jtho.2024.05.366","article-title":"Stereotactic Body radiotherapy for centrally located inoperable early-stage NSCLC: EORTC 22113\u201308113 LungTech phase II Trial results","volume":"19","author":"Levy","year":"2024","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2024.110605_b0065","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ijrobp.2024.03.050","article-title":"Stereotactic radiation for ultra-central non-small cell lung cancer: a safety and efficacy trial (SUNSET)","volume":"120","author":"Giuliani","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110605_b0070","doi-asserted-by":"crossref","unstructured":"Swaminath A, Parpia S, Wierzbicki M, et al. 2024 Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non\u2013Small Cell Lung Cancer: The LUSTRE Phase 3 Randomized Clinical Trial. JAMA Oncol. Published online September 19,. doi: 10.1001\/jamaoncol.2024.3089.","DOI":"10.1001\/jamaoncol.2024.3089"},{"key":"10.1016\/j.radonc.2024.110605_b0075","first-page":"145","article-title":"Lung SBRT credentialing in the Canadian OCOG-LUSTRE randomized trial","volume":"37","author":"Swaminath","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110605_b0080","series-title":"Basic clinical radiobiology","author":"Joiner","year":"2018"},{"key":"10.1016\/j.radonc.2024.110605_b0085","first-page":"1081","article-title":"Outcomes of hypofractionated high-dose radiotherapy in poor-risk patients with \u201cUltracentral\u201d non-small cell lung cancer","volume":"11","author":"Tekatli","year":"2016","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"10.1016\/j.radonc.2024.110605_b0090","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ijrobp.2010.12.039","article-title":"Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients","volume":"82","author":"Taremi","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110605_b0095","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1097\/JTO.0b013e31822e71d8","article-title":"Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer","volume":"6","author":"Haasbeek","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2024.110605_b0100","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.cllc.2016.05.024","article-title":"Hypofractionated intensity-modulated radiotherapy for patients with non-small-cell lung cancer","volume":"17","author":"Pollom","year":"2016","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.radonc.2024.110605_b0105","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.3747\/co.19.976","article-title":"Outcomes of accelerated hypofractionated radiotherapy in stage i non-small-cell lung cancer","volume":"19","author":"Yung","year":"2012","journal-title":"Curr Oncol"},{"key":"10.1016\/j.radonc.2024.110605_b0110","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ijrobp.2009.11.003","article-title":"Accelerated hypofractionated radiotherapy for early-stage non\u2013small-cell lung cancer: long-term results","volume":"79","author":"Soliman","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110605_b0115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1748-717X-7-33","article-title":"Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable non-small cell lung cancer","volume":"7","author":"Amini","year":"2012","journal-title":"Radiat Oncol Lond Engl"},{"key":"10.1016\/j.radonc.2024.110605_b0120","first-page":"1497","article-title":"Accelerated hypofractionated image-guided vs conventional radiotherapy for patients with stage II\/III non-small cell lung cancer and poor performance status","volume":"7","author":"Iyengar","year":"2021","journal-title":"Journal of the American Medical AssociationOncol"},{"key":"10.1016\/j.radonc.2024.110605_b0125","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju164","article-title":"Phase II study of accelerated hypofractionated three-dimensional conformal radiotherapy for stage T1\u20133 N0 M0 non-small cell lung cancer: NCIC CTG BR.25","volume":"106","author":"Cheung","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2024.110605_b0130","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1470-2045(18)30896-9","article-title":"Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial","volume":"20","author":"Ball","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110605_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2016.08.015","article-title":"SPACE - a randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC","volume":"121","author":"Nyman","year":"2016","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024042671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024042671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T05:30:09Z","timestamp":1734586209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024042671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":27,"alternative-id":["S0167814024042671"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110605","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicity in patients receiving radiotherapy for ultracentral stage I non-small cell lung cancer: A secondary analysis of the LUSTRE randomized trial","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110605","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110605"}}